Shares of Arkema S.A. (OTCMKTS:ARKAY - Get Free Report) crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $86.95 and traded as low as $72.97. Arkema shares last traded at $73.60, with a volume of 11,076 shares trading hands.
Wall Street Analysts Forecast Growth
Separately, Berenberg Bank upgraded shares of Arkema from a "hold" rating to a "strong-buy" rating in a research note on Thursday, October 31st.
Read Our Latest Analysis on ARKAY
Arkema Price Performance
The company's 50-day moving average is $79.93 and its 200-day moving average is $86.83. The firm has a market cap of $5.53 billion, a price-to-earnings ratio of 14.53, a price-to-earnings-growth ratio of 0.47 and a beta of 1.23. The company has a current ratio of 2.11, a quick ratio of 1.54 and a debt-to-equity ratio of 0.48.
Arkema (OTCMKTS:ARKAY - Get Free Report) last announced its quarterly earnings results on Wednesday, November 6th. The basic materials company reported $2.45 earnings per share (EPS) for the quarter. The company had revenue of $2.63 billion for the quarter. Arkema had a net margin of 3.82% and a return on equity of 8.04%. Equities research analysts predict that Arkema S.A. will post 9.13 earnings per share for the current year.
Arkema Company Profile
(
Get Free Report)
Arkema SA manufactures and sells specialty chemicals and advanced materials worldwide. The company operates in three segments: Adhesive Solutions, Advanced Materials and Coating Solutions, and Intermediates. The Adhesive Solutions segment provides solutions for construction, renovation of buildings, DIY, durable goods, and packaging and non-woven applications; and supplies technologies used in building activities for businesses and individuals, including sealants, tiles, flooring adhesives and waterproofing systems, and technologies used in industry, which include automotive, textiles, glazing, flexible and rigid packaging, and hygiene markets.
See Also
Before you consider Arkema, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arkema wasn't on the list.
While Arkema currently has a "Strong Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.